Florida Combined Otolaryngology Meeting 2024 – Oropharyngeal Cancer: Circulating Tumor Markers

This session focuses on the emerging role of circulating tumor HPV-DNA as a biomarker in the management of oropharyngeal cancer. Attendees will gain insights into the logistics of measuring circulating tumor DNA, its applications in guiding treatment decisions, and its utility in post-treatment surveillance. Through expert discussions, participants will explore how these advanced molecular markers are transforming patient care and improving outcomes in oropharyngeal carcinoma. Attendees will be able to: 1. Discuss the logistics behind measuring circulating tumor HPV-DNA for oropharyngeal cancer patients. 2. Describe the utility of circulating tumor DNA for treatment planning in the setting of oropharyngeal carcinoma. 3. Discuss the utility of circulating tumor DNA for post-treatment surveillance